Iodopol, 37-7400 MBq, hard capsules


21 days from the manufacturing date



Store below 25°C.


Store in the original package to avoid radiation exposure from the product.


Storage of radiopharmaceuticals should be in accordance with national regulations on radioactive materials.


Pharmaceutical form: 


Hard capsule.


Medium orange hard gelatin capsule, approximately 18 mm long, containing white powder.


Active substance: 


One capsule contains sodium iodide (131I) 37 - 7400 MBq at time of calibration.




Capsule contents:


Sodium carbonate


Sodium hydrogen carbonate


Sodium hydroxide


Disodium phosphate dihydrate


Sodium thiosulfate




Gelatin capsule shell composition:


Quinoline yellow (E 104)


Erythrosine (E 127)


Titanium dioxide (E 171)




The polypropylene vial placed in a shielding lead container, closed with a lead stopper which contains polypropylene insert with iodine absorber. The package contains a single capsule. Each package is accompanied by a separate polypropylene applicator for capsule administration.



Radioiodide thyroid therapy is indicated in adults and children for:


- hyperthyroidism: treatment of Graves’ disease, toxic multinodular goitre or autonomous nodules. 


- treatment of large euthyroid (nontoxic) goitre.


- treatment of papillary and follicular thyroid carcinoma, including metastatic disease. 


Sodium Iodide (131I) therapy is often combined with surgical intervention and with antithyroid medicinal products.





Our product range includes radiopharmaceuticals, radiochemicals, radioactivity standards and sealed radiation sources. We offer a broad selection of services and workshops, and training.

About Us

National Centre for Nuclear Research, Radioisotope Centre POLATOM is manufacturer and distributor of the isotopic goods applied in medicine, research and development, industry and environment protection.


The high professionalism of our company has been confirmed by a number of certificates including GMP for radiopharmaceutical production.